Skip to content

Clinical trials

Phase 4 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 4 Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20037
20046
20056
20072
20085
20095
20102
20111
20124
20133
20143
20154
20162
20173
20183
20192
20202
20213
20223
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Terminated9
Recruiting5
Not yet recruiting3
Unknown status3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)11
Massachusetts General Hospital5
Centre for Addiction and Mental Health4
Dartmouth-Hitchcock Medical Center4
State University of New York at Buffalo4
Yale University4
Creighton University3
Boston Medical Center2
Indivior Inc.2
Medical University of South Carolina2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders85
Opioid-Related Disorders18
Alcoholism10
Attention Deficit Disorder with Hyperactivity9
Schizophrenia9
Cocaine-Related Disorders8
Psychotic Disorders8
Bipolar Disorder6
Acquired Immunodeficiency Syndrome5
Marijuana Abuse5

Trials

Showing 26 to 50 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.